Search Results - "Foërster, F"

Physics of High-Charge Electron Beams in Laser-Plasma Wakefields by Götzfried, J., Döpp, A., Gilljohann, M. F., Foerster, F. M., Ding, H., Schindler, S., Schilling, G., Buck, A., Veisz, L., Karsch, S.

“…Laser wakefield acceleration (LWFA) and its particle-driven counterpart, particle or plasma wakefield acceleration (PWFA), are commonly treated as separate,…”
Get full text

Laser-accelerated electron beams at 1 GeV using optically-induced shock injection by v. Grafenstein, K., Foerster, F. M., Haberstroh, F., Campbell, D., Irshad, F., Salgado, F. C., Schilling, G., Travac, E., Weiße, N., Zepf, M., Döpp, A., Karsch, S.

“…In recent years, significant progress has been made in laser wakefield acceleration (LWFA), both regarding the increase in electron energy, charge and…”
Get full text

Stable and High-Quality Electron Beams from Staged Laser and Plasma Wakefield Accelerators by Foerster, F. M., Döpp, A., Haberstroh, F., Grafenstein, K. v., Campbell, D., Chang, Y.-Y., Corde, S., Couperus Cabadağ, J. P., Debus, A., Gilljohann, M. F., Habib, A. F., Heinemann, T., Hidding, B., Irman, A., Irshad, F., Knetsch, A., Kononenko, O., Martinez de la Ossa, A., Nutter, A., Pausch, R., Schilling, G., Schletter, A., Schöbel, S., Schramm, U., Travac, E., Ufer, P., Karsch, S.

“…We present experimental results on a plasma wakefield accelerator (PWFA) driven by high-current electron beams from a laser wakefield accelerator (LWFA). In…”
Get full text

Pareto Optimization and Tuning of a Laser Wakefield Accelerator by Irshad, F, Eberle, C, Foerster, F M, Grafenstein, K V, Haberstroh, F, Travac, E, Weisse, N, Karsch, S, Döpp, A

“…Optimization of accelerator performance parameters is limited by numerous trade-offs, and finding the appropriate balance between optimization goals for an…”
Get full text

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE) by Moehler, M., Heo, J., Lee, H.C., Tak, W.Y., Chao, Y., Paik, S.W., Yim, H.J., Byun, K.S., Baron, A., Ungerechts, G., Jonker, D., Ruo, L., Cho, M., Kaubisch, A., Wege, H., Merle, P., Ebert, O., Habersetzer, F., Blanc, J.F., Rosmorduc, Olivier, Lencioni, R., Patt, R., Leen, A.M., Foerster, F., Homerin, M., Stojkowitz, N., Lusky, M., Limacher, J.M., Hennequi, M., Gaspar, N., McFadden, B., De Silva, N., Shen, D., Pelusio, A., Kirn, D.H., Breitbach, C.J., Burke, J.M.

“…Pexastimogene devacirepvec (Pexa-Vec) is a vaccinia virus-based oncolytic immunotherapy designed to preferentially replicate in and destroy tumor cells while…”
Get full text

Measuring spatio-temporal couplings using modal spatio-spectral wavefront retrieval by Weisse, N, Esslinger, J, Howard, S, Foerster, F M, Haberstroh, F, Doyle, L, Norreys, P, Schreiber, J, Karsch, S, Döpp, A

“…Knowledge of spatio-temporal couplings such as pulse-front tilt or curvature is important to determine the focused intensity of high-power lasers. Common…”
Get full text

Effect of driver charge on wakefield characteristics in a plasma accelerator probed by femtosecond shadowgraphy by Schöbel, Susanne, Pausch, Richard, Chang, Yen-Yu, Corde, Sébastien, Couperus Cabadağ, Jurjen, Debus, Alexander, Ding, Hao, Döpp, Andreas, Foerster, F Moritz, Gilljohann, Max, Haberstroh, Florian, Heinemann, Thomas, Hidding, Bernhard, Karsch, Stefan, Köhler, Alexander, Kononenko, Olena, Kurz, Thomas, Nutter, Alastair, Steiniger, Klaus, Ufer, Patrick, Martinez de la Ossa, Alberto, Schramm, Ulrich, Irman, Arie

“…We report on experimental investigations of plasma wave structures in a plasma wakefield acceleration (PWFA) stage which is driven by electron beams from a…”
Get full text

Soft Reconstruction Kernels Improve HCC Imaging on a Photon-Counting Detector CT by Graafen, D., Müller, L., Halfmann, M.C., Stoehr, F., Foerster, F., Düber, C., Yang, Y., Emrich, T., Kloeckner, R.

“…Hepatocellular carcinoma (HCC) is the only tumor entity that allows non-invasive diagnosis based on imaging without further histological proof. Therefore,…”
Get full text

Detection of posture and motion by accelerometry: a validation study in ambulatory monitoring by Foerster, F, Smeja, M, Fahrenberg, J

“…The suitable placement of a small number of calibrated piezoresistive accelerometer devices may suffice to assess postures and motions reliably. This finding,…”
Get full text

Development of prosaccade and antisaccade task performance in participants aged 6 to 26 years by KLEIN, C., FOERSTER, F.

“…There are few studies on the development of oculomotor functions during childhood. B. Fischer, M. Biscaldi, and S. Gezeck (1997) reported improvement of…”
Get full text

Targeting the actin cytoskeleton: selective antitumor action via trapping PKC epsilon by Foerster, F, Braig, S, Moser, C, Kubisch, R, Busse, J, Wagner, E, Schmoeckel, E, Mayr, D, Schmitt, S, Huettel, S, Zischka, H, Mueller, R, Vollmar, A M

“…Targeting the actin cytoskeleton (CSK) of cancer cells offers a valuable strategy in cancer therapy. There are a number of natural compounds that interfere…”
Get full text

Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study by Mavratzas, A., Baek, S., Gerber, B., Schmidt, M., Moebus, V., Foerster, F., Grischke, E.M., Fasching, P., Strumberg, D., Solomayer, E., Klare, P., Windemuth-Kieselbach, C., Hartmann, S., Schneeweiss, A., Marmé, F.

“…This multicenter, double-blind phase II study assessed the antitumor activity and toxicity profile of docetaxel with the antiangiogenic multikinase inhibitor…”
Get full text

In Vivo Myofibroblast Specific Gene Silencing in the Liver Using Novel Sirna-Loaded Biodegradable Nanohydrogel Particles by Kaps, L, Nuhn, L, Aslam, M, Brose, A, Foerster, F, Zentel, R, Schuppan, D

Get full text

Gas-dynamic density downramp injection in a beam-driven plasma wakefield accelerator by Couperus Cabadağ, J. P., Pausch, R., Schöbel, S., Bussmann, M., Chang, Y.-Y., Corde, S., Debus, A., Ding, H., Döpp, A., Foerster, F. M., Gilljohann, M., Haberstroh, F., Heinemann, T., Hidding, B., Karsch, S., Koehler, A., Kononenko, O., Knetsch, A., Kurz, T., Martinez de la Ossa, A., Nutter, A., Raj, G., Steiniger, K., Schramm, U., Ufer, P., Irman, A.

“…We present the experimental demonstration of density downramp injection at a gas-dynamic shock in a beam-driven plasma accelerator. The ultrashort driver…”
Get full text

P0419 : In vivo cell specific gene silencing in the liver using novel siRNA-loaded nanohydrogel particles by Kaps, L, Nuhn, L, Foerster, F, Brose, A, Heck, R, Diken, M, Zentel, R, Schuppan, D

Get full text

P0312 : Preclinical evaluation of dextran-based therapeutic nanoparticles for hepatic drug delivery by Foerster, F, Kaps, L, Brose, A, Strobl, S, Bamberger, D, Diken, M, Tüttenberg, A, Wich, P, Schuppan, D

Get full text

1869 Disease characteristics of subgroup patients treated with everolimus + exemestane for <12 months, ≥12 to <18months, and ≥18 months - Results of the 3rd interim analysis of the non-interventional trial BRAWO by Lüftner, D, Grischke, E.M, Fasching, P, Decker, T, Schneeweiss, A, Uleer, C, Foerster, F, Wimberger, P, Kluth-Pepper, B, Schubert, J, Bloch, W, Tesch, H, Schuetz, F, Jackisch, C

Get full text

P0311 : Balb/c and C57/Bl6 mice exhibit differences in their susceptibility and anti-tumor response to B16F10 melanoma liver metastasis by Foerster, F, Strobl, S, Kaps, L, Weng, S.-Y, Kim, Y.O, Bros, M, Diken, M, Boegel, S, Castle, J, Bockamp, E, Schuppan, D

Get full text

Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure by Foerster, F, Wörns, M A, Galle, P R, Schattenberg, J M

“…Direct acting antivirals (DAAs) have increased cure rates for chronic hepatitis C infection up to nearly 100 %. At the same time treatment costs have risen…”
Get more information

Telepathology and second opinion for cancer diagnosis in sub-Saharan French-speaking countries by Petit, L, Ilunga, J, Foërster, F, Traore, C, Anani, L, Lebwaze, B, N’Kegoum, B, Hurwitz, N, Raphaël, M, Gagnepain-Lacheteau, A

“…Abstract Many healthcare disparities can be described to explain cancer prevalence differences between developed and developing countries. Telepathology,…”
Get full text